Glaucoma – Early Detection & Management

Glaucoma research emphasizes early detection, risk stratification, and sustainable long-term management to prevent irreversible optic nerve damage. Advanced imaging tools, including OCT-angiography and high-resolution nerve fiber analysis, provide clinicians with precise indicators of microvascular compromise and early structural loss. AI-driven algorithms are enhancing screening accuracy, particularly for high-risk populations lacking regular access to ophthalmic care. Treatment options continue to evolve with minimally invasive glaucoma surgeries (MIGS), novel drainage implants, and laser-based interventions designed to reduce intraocular pressure with minimal tissue disruption. Neuroprotective agents and sustained-release drug delivery platforms are being explored to preserve retinal ganglion cell function beyond pressure reduction alone. Personalized management strategies consider central corneal thickness, genetic predisposition, and progression patterns to optimize outcomes. These innovations collectively support earlier intervention, reduced treatment burden, and improved quality of life for patients across diverse clinical stages.

    Related Conference of Glaucoma – Early Detection & Management

    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain
    September 14-15, 2026

    40th European Ophthalmology Congress

    Rome, Italy
    September 14-15, 2026

    7th World Congress on Ophthalmology and Vision Science

    Rome, Italy

    Glaucoma – Early Detection & Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in